By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ProUroCare Medical Inc.

ProUroCare Medical Inc. (PUMD)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 20 Aug 2025, 20:00
$3.72K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

PUMD Stock Price Chart

Explore ProUroCare Medical Inc. interactive price chart. Choose custom timeframes to analyze PUMD price movements and trends.

PUMD Company Profile

Discover essential business fundamentals and corporate details for ProUroCare Medical Inc. (PUMD) to support your stock research and investment decisions.

Sector

Technology

Industry

Consumer Electronics

IPO Date

29 Nov 2022

Employees

2.00

CEO

Benjamin Banks

Description

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

PUMD Financial Timeline

Browse a chronological timeline of ProUroCare Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

PUMD Stock Performance

Access detailed PUMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run